EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of Renshen Yangying Decoction Combined with Chemotherapy on Traditional Chinese Medical Symptoms and T Cell Subsets in Patients with Cervical Cancer of Ganyu Qizhi Type

Zijie Yin, Xueqin Hou

Journal of Experimental and Clinical Application of Chinese Medicine · 2022

DOI: 10.62767/jecacm304.3789 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental and Clinical Application of Chinese Medicine, 2022. Verfasst von Zijie Yin und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To confirm the effects of the combination of Renshen Yangying decoction and chemotherapy on traditional Chinese medical symptoms and T cell subsets in patients with cervical cancer (CC) of Ganyu Qizhi type.

Methods

Patients with CC of Ganyu Qizhi type admitted to our hospital (n=96) were selected and evenly divided into control and observation groups. The patients in control group received chemotherapy, while those in observation group were additionally treated with Renshen Yangying decoction. The clinical efficacy, traditional Chinese medical symptom (TCMS) score, serum tumor markers, changes of serum T lymphocyte subsets and adverse effects were compared.

Results

The distribution of clinical efficacy grade in all patients after treatment was statistically significant, and the clinical benefit rate (CBR) of observation group was higher than that of control group. The TCMS score, the serum carcinoembryonic antigen (CEA), squamous cell carcinoma antigen (SCCA), and cancer antigen 125 (CA125) were also decreased after treatment, and those were decreased in observation group. Levels of serum CD4+ and CD4+/CD8+, and natural killer (NK) cell percentage were higher, yet serum CD8+ cell percentage was lower after treatment, and in patients of observation group, levels of serum CD4+ and CD4+/CD8+, and NK cell percentage were higher, yet serum CD8+ cell percentage was lower. The incidence of adverse effects in the observation group was lower than that in the control group.

Conclusion

Renshen Yangying decoction combined with chemotherapy in the treatment of CC of Ganyu Qizhi type can alleviate the clinical symptoms, reduce serum tumor markers, and improve the cellular immunity, with significant clinical efficacy and good safety on patients.

Zitieren

APA

Yin, Z., & Hou, X. (2022). Effect of Renshen Yangying Decoction Combined with Chemotherapy on Traditional Chinese Medical Symptoms and T Cell Subsets in Patients with Cervical Cancer of Ganyu Qizhi Type. Journal of Experimental and Clinical Application of Chinese Medicine. https://doi.org/10.62767/jecacm304.3789

Vancouver

Yin Z, Hou X. Effect of Renshen Yangying Decoction Combined with Chemotherapy on Traditional Chinese Medical Symptoms and T Cell Subsets in Patients with Cervical Cancer of Ganyu Qizhi Type. Journal of Experimental and Clinical Application of Chinese Medicine. 2022. doi:10.62767/jecacm304.3789

BibTeX
@article{Yin2022,
  author = {Yin, Zijie and Hou, Xueqin},
  title = {Effect of Renshen Yangying Decoction Combined with Chemotherapy on Traditional Chinese Medical Symptoms and T Cell Subsets in Patients with Cervical Cancer of Ganyu Qizhi Type},
  journal = {Journal of Experimental and Clinical Application of Chinese Medicine},
  year = {2022},
  doi = {10.62767/jecacm304.3789}
}
Kostenlos starten →